(3S)-3-(3-(2-cyclopentyl-2-(4-(5-isobutylpyridin-3-yl)phenyl)acetamido)-2-methylphenyl)pentanoic acid

ID: ALA4459950

Chembl Id: CHEMBL4459950

PubChem CID: 155527581

Max Phase: Preclinical

Molecular Formula: C34H42N2O3

Molecular Weight: 526.72

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@@H](CC(=O)O)c1cccc(NC(=O)C(c2ccc(-c3cncc(CC(C)C)c3)cc2)C2CCCC2)c1C

Standard InChI:  InChI=1S/C34H42N2O3/c1-5-25(19-32(37)38)30-11-8-12-31(23(30)4)36-34(39)33(27-9-6-7-10-27)28-15-13-26(14-16-28)29-18-24(17-22(2)3)20-35-21-29/h8,11-16,18,20-22,25,27,33H,5-7,9-10,17,19H2,1-4H3,(H,36,39)(H,37,38)/t25-,33?/m0/s1

Standard InChI Key:  OYYPUWHVMWNOPI-CPMFFWQLSA-N

Alternative Forms

  1. Parent:

    ALA4459950

    ---

Associated Targets(Human)

PTGES Tchem Prostaglandin E synthase (3082 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ptges Prostaglandin E synthase (86 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 526.72Molecular Weight (Monoisotopic): 526.3195AlogP: 8.14#Rotatable Bonds: 11
Polar Surface Area: 79.29Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.27CX Basic pKa: 5.22CX LogP: 7.25CX LogD: 5.37
Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.26Np Likeness Score: -0.52

References

1. Koppitz M, Bräuer N, Ter Laak A, Irlbacher H, Rotgeri A, Coelho AM, Walter D, Steinmeyer A, Zollner TM, Peters M, Nagel J..  (2019)  Discovery and optimization of pyridyl-cycloalkyl-carboxylic acids as inhibitors of microsomal prostaglandin E synthase-1 for the treatment of endometriosis.,  29  (18): [PMID:31362919] [10.1016/j.bmcl.2019.07.007]

Source